에스테르계 화합물, 이를 포함하는 가소제 조성물, 이의 제조방법, 및 이를 포함하는 수지 조성물
    1.
    发明申请
    에스테르계 화합물, 이를 포함하는 가소제 조성물, 이의 제조방법, 및 이를 포함하는 수지 조성물 审中-公开
    ESTER化合物,包含其的增塑剂组合物,制造增塑剂组合物的方法和包含增塑剂组合物的树脂组合物

    公开(公告)号:WO2015119442A1

    公开(公告)日:2015-08-13

    申请号:PCT/KR2015/001202

    申请日:2015-02-05

    CPC classification number: C07C67/08 C07C69/80 C08K5/0016 C08K5/11 C08L27/06

    Abstract: 이소프탈레이트계 에스테르 화합물, 및 이를 포함하는 가소제 조성물, 상기 가소제 조성물의 제조방법 및 상기 가소제 조성물을 포함하는 수지 조성물을 제공한다. 상기 신규 에스테르 화합물은 수지 조성물에 사용할 경우, 친환경적이면서, 우수한 가소화 효율, 인장강도와 신율 뿐만 아니라, 내이행성 및 내휘발성 등의 우수한 물성을 제공할 수 있다.

    Abstract translation: 提供了基于间苯二甲酸酯的酯化合物,包含其的增塑剂组合物,增塑剂组合物的制造方法和包含该增塑剂组合物的树脂组合物。 当用于树脂组合物时,新型酯化合物是环境友好的,并且可以提供优异的物理特性,例如优异的增塑效率,拉伸强度和伸长率,以及耐渗透性和耐挥发性。

    BIOACTIVE DEPSIDE AND ANTHOCYANIN COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
    3.
    发明申请
    BIOACTIVE DEPSIDE AND ANTHOCYANIN COMPOUNDS, COMPOSITIONS, AND METHODS OF USE 审中-公开
    生物灭活剂和蒽醌化合物,组合物和使用方法

    公开(公告)号:WO2008016593A3

    公开(公告)日:2008-08-21

    申请号:PCT/US2007017087

    申请日:2007-07-31

    Abstract: Methods for modulating the level of a chemokine in a cell by administering to a cell an effective amount of a depside or an anthocyanin are provided. More particularly, a method for modulating the level of a chemokine in a cell by administering to a cell an effective amount of a depside having the structure of formula (IV): Formula (IV) wherein R is selected from H or CH 3 or an anthocyanin selected from cyanidin 3-glucoside, delphinidin 3-glucoside, or combinations thereof, or an enantiomer, optical isomer, diastereomer, N-oxide, crystalline form, hydrate, or pharmaceutically acceptable salt thereof is provided. Also provided are compounds according to Formulas I-IV, pharmaceutical compositions, unit dosage forms, and food or feed supplements containing such compounds. Methods for treating a condition in a mammal and for treating or ameliorating a condition, such as for example, chronic obstructive pulmonary disease (COPD) by administering an effective amount of a composition containing such compounds are also provided. Further provided is an extract obtained from the fruit ofMyrciaria ca?liflora containing at least one compound of the present invention in substantially pure form.

    Abstract translation: 提供了通过向细胞施用有效量的底部或花青素来调节细胞中趋化因子水平的方法。 更具体地,涉及一种通过向细胞施用有效量的具有式(IV)结构的底物:调节细胞中趋化因子水平的方法:式(IV)其中R选自H或CH 或选自花青素3-葡萄糖苷,花翠素-3-葡萄糖苷或其组合的花青素,或其对映异构体,旋光异构体,非对映异构体,N-氧化物,结晶形式,水合物或其药学上可接受的盐。 还提供了根据式I-IV的化合物,药物组合物,单位剂型,以及含有这些化合物的食品或饲料添加剂。 还提供了通过施用有效量的含有这些化合物的组合物来治疗哺乳动物状况和治疗或改善病症的方法,例如慢性阻塞性肺病(COPD)。 进一步提供了从含有至少一种基本上纯的形式的本发明化合物的马鞭草果实获得的提取物。

    OLIGOMERIC HALOGENATED DIPHENYL ETHER COMPOUNDS
    7.
    发明申请
    OLIGOMERIC HALOGENATED DIPHENYL ETHER COMPOUNDS 审中-公开
    低分子卤化二苯醚化合物

    公开(公告)号:WO99038830A1

    公开(公告)日:1999-08-05

    申请号:PCT/EP1999/000427

    申请日:1999-01-22

    CPC classification number: C08G65/22 C07C43/295

    Abstract: The invention describes oligomeric halogenated diphenyl ether compounds of formula (1), in which Y is the radical of formula (1a); (1b); or (1c); R1 and R2 independently of one another are F, Cl or Br; R3 is the radical of an initiator molecular for the free-radical polymerization; R4 is hydrogen; or C1-C5 alkyl; R5 is the radical of an initiator molecule for the anionic or cationic polymerization; A1 is a fragment from the recombination or from a chain transfer reaction; A2 is the counterion in the ionic polymerization; Q1 is a bivalent radical of formulae: (1d); (1e); (1f); or (1g); m is 1 to 3; n is 1 or 2; p1 is 0, or 1; q1 is 1, 2 or 3; and r1, r2 and r3 independently of one another are 2-20. The oligomeric diphenyl ether compounds according to the invention have excellent antimicrobial properties and are stable to migration.

    Abstract translation: 本发明描述了式(1)的低聚卤化二苯醚化合物,其中Y是式(1a)的基团; (1B); 或(1c); R 1和R 2彼此独立地是F,Cl或Br; R3是自由基聚合的引发剂分子的基团; R4是氢; 或C 1 -C 5烷基; R5是阴离子或阳离子聚合的引发剂分子的基团; A1是来自重组或链转移反应的片段; A2是离子聚合中的抗衡离子; Q1是式的二价基团:(1d); (1E); (1F); 或(1g); m为1〜3; n为1或2; p1为0或1; q1为1,2或3; 而r1,r2和r3彼此独立地为2-20。 根据本发明的低聚二苯醚化合物具有优异的抗菌性能并且对迁移稳定。

    NOVEL ALKANOYL ESTER COMPOUNDS, INTERMEDIATES THEREFOR, AND PROCESSES FOR THEIR PREPARATION
    8.
    发明申请
    NOVEL ALKANOYL ESTER COMPOUNDS, INTERMEDIATES THEREFOR, AND PROCESSES FOR THEIR PREPARATION 审中-公开
    新的烷基酯化合物,其中间体及其制备方法

    公开(公告)号:WO1988007518A1

    公开(公告)日:1988-10-06

    申请号:PCT/JP1988000334

    申请日:1988-03-31

    CPC classification number: C09K19/2021

    Abstract: Novel alkanoyl ester compounds represented by general formula (I) (wherein A represents -, -O-, (II), (III), (IV) or (V), B represents (II) or (III), l and m each represents 1 or 2, provided that l and m do not represent 2 at the same time, k and n each represents an integer of 1 or more, with k > n, and R represents an alkyl group), a liquid crystal containing same, novel alkanoylphenyl compounds to be used as intermediates for preparing them, novel alkanoylbiphenyl compounds, and processes for their preparation are disclosed. The novel alkanoyl ester compounds have excellent stability to light, etc. and can take a liquid crystal form over a wide temperature range. Introduction of an optically active group into the compounds provides strongly dielectric liquid crystals showing large spontaneous polarization and rapid response. Thus, the compounds can be utilized as materials for optoelectronics-related elements.

Patent Agency Ranking